139 related articles for article (PubMed ID: 38677041)
1. Investigating locations of recurrences with MRI after CRS-HIPEC for colorectal peritoneal metastases.
Rijsemus CJV; Kok NFM; Aalbers AGJ; Grotenhuis BA; Berardi E; Snaebjornsson P; Lambregts DMJ; Beets-Tan RGH; Lahaye MJ
Eur J Radiol; 2024 Jun; 175():111478. PubMed ID: 38677041
[TBL] [Abstract][Full Text] [Related]
2. Extent of Peritoneal Metastases on Preoperative DW-MRI is Predictive of Disease-Free and Overall Survival for CRS/HIPEC Candidates with Colorectal Cancer.
Engbersen MP; Aalbers AGJ; Van't Sant-Jansen I; Velsing JDR; Lambregts DMJ; Beets-Tan RGH; Kok NFM; Lahaye MJ
Ann Surg Oncol; 2020 Sep; 27(9):3516-3524. PubMed ID: 32239338
[TBL] [Abstract][Full Text] [Related]
3. Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Birgisson H; Enblad M; Artursson S; Ghanipour L; Cashin P; Graf W
Eur J Surg Oncol; 2020 Dec; 46(12):2283-2291. PubMed ID: 32873455
[TBL] [Abstract][Full Text] [Related]
4. Development of a prediction model for recurrence in patients with colorectal peritoneal metastases undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Dietz MV; Hannink G; Said I; van der Zant FA; van de Vlasakker VCJ; Brandt-Kerkhof ARM; Verhoef C; Bremers AJA; de Wilt JHW; Hemmer PHJ; de Hingh IHJT; de Reuver PR; Madsen EVE
Eur J Surg Oncol; 2024 Jun; 50(6):108294. PubMed ID: 38583215
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Isolated Peritoneal Recurrences in Patients with Colorectal Peritoneal Metastases Previously Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
van Eden WJ; Elekonawo FMK; Starremans BJ; Kok NFM; Bremers AJA; de Wilt JHW; Aalbers AGJ
Ann Surg Oncol; 2018 Jul; 25(7):1992-2001. PubMed ID: 29671139
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of MRI for staging peritoneal metastases in patients with colorectal cancer after neoadjuvant chemotherapy.
Rijsemus CJV; Kok NFM; Aalbers AGJ; Buffart TE; Fijneman RJA; Snaebjornsson P; Engbersen MP; Lambregts DMJ; Beets-Tan RGH; Lahaye MJ
Eur J Radiol; 2022 Apr; 149():110225. PubMed ID: 35255321
[TBL] [Abstract][Full Text] [Related]
7. Dedicated MRI staging versus surgical staging of peritoneal metastases in colorectal cancer patients considered for CRS-HIPEC; the DISCO randomized multicenter trial.
Engbersen MP; Rijsemus CJV; Nederend J; Aalbers AGJ; de Hingh IHJT; Retel V; Lambregts DMJ; Van der Hoeven EJRJ; Boerma D; Wiezer MJ; De Vries M; Madsen EVE; Brandt-Kerkhof ARM; Van Koeverden S; De Reuver PR; Beets-Tan RGH; Kok NFM; Lahaye MJ
BMC Cancer; 2021 Apr; 21(1):464. PubMed ID: 33902498
[TBL] [Abstract][Full Text] [Related]
8. Patterns and Timing of Recurrence following CRS and HIPEC in Colorectal Cancer Peritoneal Metastasis.
Hassan S; Malcomson L; Soh YJ; Wilson MS; Clouston H; O'Dwyer ST; Kochhar R; Aziz O
Eur J Surg Oncol; 2023 Jan; 49(1):202-208. PubMed ID: 35987797
[TBL] [Abstract][Full Text] [Related]
9. [Construction and evaluation of a nomogram for predicting the prognosis of patients with colorectal cancer with peritoneal carcinomatosis treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
An SL; Ji ZH; Li XB; Liu G; Zhang YB; Gao C; Zhang K; Zhang XJ; Yan GJ; Yan LJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):434-441. PubMed ID: 37217351
[No Abstract] [Full Text] [Related]
10. Adding diagnostic laparoscopy to computed tomography for the evaluation of peritoneal metastases in patients with colorectal cancer: A retrospective cohort study.
Leimkühler M; de Haas RJ; Pol VEH; Hemmer PHJ; Been LB; van Ginkel RJ; Kruijff S; de Bock GH; van Leeuwen BL
Surg Oncol; 2020 Jun; 33():135-140. PubMed ID: 32561078
[TBL] [Abstract][Full Text] [Related]
11. Seeing the whole picture: Added value of MRI for extraperitoneal findings in CRS-HIPEC candidates.
van 't Sant I; Nerad E; Rijsemus CJV; Engbersen MP; Gispen CA; Lambregts DMJ; Beets-Tan RGH; Aalbers AGJ; Kok NFM; Lahaye MJ
Eur J Surg Oncol; 2022 Feb; 48(2):462-469. PubMed ID: 34563410
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Stable Lung Colorectal Metastases on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Pantelis A; Ben-Yaacov A; Adileh M; Schtrechman G; Shacham-Shmueli E; Boursi B; Margalit O; Halpern N; Mor E; Assaf D; Maximiliano K; Nissan A; Laks S
J Gastrointest Surg; 2022 Aug; 26(8):1724-1731. PubMed ID: 35768716
[TBL] [Abstract][Full Text] [Related]
13. Direct surgery with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastases.
Ljunggren M; Nordenvall C; Palmer G
Eur J Surg Oncol; 2021 Nov; 47(11):2865-2872. PubMed ID: 34116900
[TBL] [Abstract][Full Text] [Related]
14. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases - The Hong Kong experience and literature review.
Chow FC; Yip J; Foo DC; Wei R; Choi HK; Ng KK; Lo OS
Asian J Surg; 2021 Jan; 44(1):221-228. PubMed ID: 32605790
[TBL] [Abstract][Full Text] [Related]
15. Hepatectomy for metachronous colorectal liver metastases following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases: a report of three cases.
Ito K; Takemura N; Inagaki F; Mihara F; Kurokawa T; Gohda Y; Kiyomatsu T; Yano H; Kokudo N
World J Surg Oncol; 2019 Jun; 17(1):99. PubMed ID: 31196097
[TBL] [Abstract][Full Text] [Related]
16. Sites of Recurrence After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis from Colorectal and Appendiceal Adenocarcinoma: A Tertiary Center Experience.
Feferman Y; Solomon D; Bhagwandin S; Kim J; Aycart SN; Feingold D; Sarpel U; Labow DM
Ann Surg Oncol; 2019 Feb; 26(2):482-489. PubMed ID: 30539491
[TBL] [Abstract][Full Text] [Related]
17. Short and long-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal and appendiceal cancer peritoneal metastasis: Propensity score-matched comparison between laparoscopy vs. open approaches.
Chang SC; Fingerhut A; Chen WT
Surg Oncol; 2022 Aug; 43():101766. PubMed ID: 35430126
[TBL] [Abstract][Full Text] [Related]
18. Age alone is not a barrier to efficacy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: analysis of 1138 patients from the UK and Ireland Colorectal Peritoneal Metastases Registry.
Kelly ME; O'Sullivan NJ; Bolger JC; Polignano F; Youssef H; Renehan A; Malcomson L; Alves S; Cecil T; Mulsow J; Moran B; Mohamed F;
Br J Cancer; 2023 Jan; 128(1):42-47. PubMed ID: 36347966
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
[No Abstract] [Full Text] [Related]
20. Management of colorectal cancer patients at high risk of peritoneal metastases.
Shariff U; Seretis C; Youssef H
J BUON; 2015 May; 20 Suppl 1():S71-9. PubMed ID: 26051336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
